ARTICLE | Clinical News
Betalutin: Phase I/II expanded
October 26, 2015 7:00 AM UTC
Nordic will expand the ongoing, open-label, dose-escalation, European Phase I/II LYMRIT-37-01 trial evaluating single injections of Betalutin to include a dose-finding portion. Previously, the dose-fi...